The protein kinase IKKε is a potential target for the treatment of inflammatory hyperalgesia

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2617-2625

  Möser, Christine V ^a   Kynast, Katharina ^a   Baatz, Katharina ^a   Russe, Otto Quintus ^a   Ferreiroś, Nerea ^a   Costiuk, Heike ^a   Lu, Ruirui ^a   Schmidtko, Achim ^a   Tegeder, Irmgard ^a   Geisslinger, Gerd ^a   Niederberger, Ellen ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BX 795; CYCLOOXYGENASE 2; FORMALDEHYDE; GELATINASE B; I KAPPA B KINASE EPSILON; I KAPPA B KINASE EPSILON INHIBITOR; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG SPINAL CORD LEVEL; DRUG TARGETING; DRUG TISSUE LEVEL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; HYPERALGESIA; KNOCKOUT MOUSE; MALE; MECHANICAL STIMULATION; MOUSE; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD NERVE CELL; SPINAL GANGLION; THERMAL EXPOSURE; TRANSCRIPTION INITIATION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIA, SPINAL; HYPERALGESIA; I-KAPPA B KINASE; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 80052686058     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004088     Document Type: Article

References (40)

1. Niederberger, E., and G. Geisslinger. 2008. The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? FASEB J. 22: 3432-3442.
2. Yamamoto, Y., and R. B. Gaynor. 2004. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci. 29: 72-79. (Pubitemid 38186577)
3. Häcker, H., and M. Karin. 2006. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006: re13.
4. Viatour, P., M. P. Merville, V. Bours, and A. Chariot. 2005. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30: 43-52. (Pubitemid 40093740)
5. Karin, M., Y. Yamamoto, and Q. M. Wang. 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3: 17-26. (Pubitemid 38088695)
6. Peters, R. T., and T. Maniatis. 2001. A new family of IKK-related kinases may function as I kappa B kinase kinases. Biochim. Biophys. Acta 1471: M57-M62.
7. Shimada, T., T. Kawai, K. Takeda, M. Matsumoto, J. Inoue, Y. Tatsumi, A. Kanamaru, and S. Akira. 1999. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int. Immunol. 11: 1357-1362. (Pubitemid 29355675)
8. Sharma, S., B. R. tenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151. (Pubitemid 36583100)
9. McWhirter, S. M., K. A. Fitzgerald, J. Rosains, D. C. Rowe, D. T. Golenbock, and T. Maniatis. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101: 233-238. (Pubitemid 38084233)
10. Buss, H., A. Dörrie, M. L. Schmitz, E. Hoffmann, K. Resch, and M. Kracht. 2004. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-kappaB at serine 536 is mediated by multiple protein kinases including IkappaB kinase (IKK)-alpha, IKKbeta, IKKepsilon, TRAF family memberassociated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 279: 55633-55643. (Pubitemid 40068850)
11. Adli, M., and A. S. Baldwin. 2006. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J. Biol. Chem. 281: 26976-26984. (Pubitemid 44401726)
12. Mattioli, I., H. Geng, A. Sebald, M. Hodel, C. Bucher, M. Kracht, and M. L. Schmitz. 2006. Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J. Biol. Chem. 281: 6175-6183. (Pubitemid 43847547)
13. Harris, J., S. Olière, S. Sharma, Q. Sun, R. Lin, J. Hiscott, and N. Grandvaux. 2006. Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon. J. Immunol. 177: 2527-2535. (Pubitemid 44202170)
14. Kravchenko, V. V., J. C. Mathison, K. Schwamborn, F. Mercurio, and R. J. Ulevitch. 2003. IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli. J. Biol. Chem. 278: 26612-26619. (Pubitemid 36876806)
15. Sweeney, S. E., D. Hammaker, D. L. Boyle, and G. S. Firestein. 2005. Regulation of c-Jun phosphorylation by the I kappa B kinase-epsilon complex in fibroblast-like synoviocytes. J. Immunol. 174: 6424-6430. (Pubitemid 40663836)
16. Aupperle, K. R., Y. Yamanishi, B. L. Bennett, F. Mercurio, D. L. Boyle, and G. S. Firestein. 2001. Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell. Immunol. 214: 54-59. (Pubitemid 34280756)
17. Hemmi, H., O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, T. Kawai, K. Hoshino, K. Takeda, and S. Akira. 2004. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199: 1641-1650. (Pubitemid 38821997)
18. Clark, K., L. Plater, M. Peggie, and P. Cohen. 2009. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 284: 14136-14146.
19. Mogil, J. S., S. G. Wilson, K. Bon, S. E. Lee, K. Chung, P. Raber, J. O. Pieper, H. S. Hain, J. K. Belknap, L. Hubert, et al. 1999. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 80: 67-82. (Pubitemid 29151691)
20. Dubuisson, D., and S. G. Dennis. 1977. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174. (Pubitemid 8234766)
21. Meller, S. T., and G. F. Gebhart. 1997. Intraplantar zymosan as a reliable, quantifiable model of thermal and mechanical hyperalgesia in the rat. Eur. J. Pain 1: 43-52. (Pubitemid 127675871)
22. Silverman, J. D., and L. Kruger. 1990. Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markers. J. Neurocytol. 19: 789-801. (Pubitemid 20378878)
23. Kaltschmidt, C., B. Kaltschmidt, H. Neumann, H. Wekerle, and P. A. Baeuerle. 1994. Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14: 3981-3992.
24. Coderre, T. J., K. Yashpal, and J. L. Henry. 1994. Specific contribution of lumbar spinal mechanisms to persistent nociceptive responses in the formalin test. Neuroreport 5: 1337-1340. (Pubitemid 24219226)
25. Kunz, S., I. Tegeder, O. Coste, C. Marian, A. Pfenninger, C. Corvey, M. Karas, G. Geisslinger, and E. Niederberger. 2005. Comparative proteomic analysis of the rat spinal cord in inflammatory and neuropathic pain models. Neurosci. Lett. 381: 289-293. (Pubitemid 40719173)
26. Niederberger, E., I. Tegeder, C. Schäfer, M. Seegel, S. Grösch, and G. Geisslinger. 2003. Opposite effects of rofecoxib on nuclear factor-kappaB and activating protein-1 activation. J. Pharmacol. Exp. Ther. 304: 1153-1160. (Pubitemid 36254428)
27. Hunskaar, S., and K. Hole. 1987. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30: 103-114. (Pubitemid 17094194)
28. Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13: 460-469.
29. Malmberg, A. B., and T. L. Yaksh. 1995. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J. Neurosci. 15: 2768-2776.
30. Schmidtko, A., I. Tegeder, and G. Geisslinger. 2009. No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci. 32: 339-346.
31. Kawasaki, Y., Z. Z. Xu, X. Wang, J. Y. Park, Z. Y. Zhuang, P. H. Tan, Y. J. Gao, K. Roy, G. Corfas, E. H. Lo, and R. R. Ji. 2008. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med. 14: 331-336. (Pubitemid 351347915)
32. St-Pierre, Y., J. Couillard, and C. Van Themsche. 2004. Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases. Expert Opin. Ther. Targets 8: 473-489. (Pubitemid 39359652)
33. Niederberger, E., A. Schmidtko, W. Gao, H. Kühlein, C. Ehnert, and G. Geisslinger. 2007. Impaired acute and inflammatory nociception in mice lacking the p50 subunit of NF-kappaB. Eur. J. Pharmacol. 559: 55-60. (Pubitemid 46274646)
34. Tegeder, I., E. Niederberger, R. Schmidt, S. Kunz, H. Gühring, O. Ritzeler, M. Michaelis, and G. Geisslinger. 2004. Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J. Neurosci. 24: 1637-1645. (Pubitemid 38240959)
35. Ebersberger, A., M. Buchmann, O. Ritzeler, M. Michaelis, and H. G. Schaible. 2006. The role of spinal nuclear factor-kappa B in spinal hyperexcitability. Neuroreport 17: 1615-1618. (Pubitemid 44454767)
36. Bockhart, V., C. E. Constantin, A. Häussler, N. Wijnvoord, M. Kanngiesser, T. Myrczek, G. Pickert, L. Popp, J. M. Sobotzik, M. Pasparakis, et al. 2009. Inhibitor kappaB Kinase beta deficiency in primary nociceptive neurons increases TRP channel sensitivity. J. Neurosci. 29: 12919-12929.
37. Li, Q., D. Van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284: 321-325. (Pubitemid 129523450)
38. Li, Q., Q. Lu, J. Y. Hwang, D. Büscher, K. F. Lee, J. C. Izpisua-Belmonte, and I. M. Verma. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13: 1322-1328. (Pubitemid 29250199)
39. Tanaka, M., M. E. Fuentes, K. Yamaguchi, M. H. Durnin, S. A. Dalrymple, K. L. Hardy, and D. V. Goeddel. 1999. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10: 421-429. (Pubitemid 29205478)
40. Rudolph, D., W. C. Yeh, A. Wakeham, B. Rudolph, D. Nallainathan, J. Potter, A. J. Elia, and T. W. Mak. 2000. Severe liver degeneration and lack of NFkappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14: 854-862. (Pubitemid 30215004)